Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Low-grade inflammation connects aging, obesity and cognitive impairment

Low-grade inflammation connects aging, obesity and cognitive impairment

Engineered CAR-T cells reduce Alzheimer’s plaques in mice

Engineered CAR-T cells reduce Alzheimer’s plaques in mice

Brain immune cells regulate new neuron formation in adults

Brain immune cells regulate new neuron formation in adults

AI-powered tool automatically segments human brainstem white matter bundles

AI-powered tool automatically segments human brainstem white matter bundles

Cognitive speed training shows potential to delay dementia for two decades

Cognitive speed training shows potential to delay dementia for two decades

Inhibiting PTP1B protein improves memory in Alzheimer’s disease models

Inhibiting PTP1B protein improves memory in Alzheimer’s disease models

Breastfeeding and pregnancy linked to improved postmenopausal cognition

Breastfeeding and pregnancy linked to improved postmenopausal cognition

Most commercially insured patients live with chronic conditions

Most commercially insured patients live with chronic conditions

Aging brains struggle to recycle synaptic proteins

Aging brains struggle to recycle synaptic proteins

Researchers uncover a new cellular process linked to healthy aging

Researchers uncover a new cellular process linked to healthy aging

Distinct tau chemical signatures redefine diagnosis across neurodegenerative diseases

Distinct tau chemical signatures redefine diagnosis across neurodegenerative diseases

Hippocampus reorganizes memories to anticipate future outcomes, study finds

Hippocampus reorganizes memories to anticipate future outcomes, study finds

Research uncovers why certain brain cells are more resilient to tau protein buildup

Research uncovers why certain brain cells are more resilient to tau protein buildup

Study uncovers how the brain's 'memory replay' process is impaired in Alzheimer's disease

Study uncovers how the brain's 'memory replay' process is impaired in Alzheimer's disease

People with cerebral amyloid angiopathy more likely to develop dementia

People with cerebral amyloid angiopathy more likely to develop dementia

Older adults' driving habits may provide early warning signs of cognitive decline or dementia

Older adults' driving habits may provide early warning signs of cognitive decline or dementia

Combination therapy improves cognition in Alzheimer’s models

Combination therapy improves cognition in Alzheimer’s models

Brain protein CUL5 protects neurons by clearing toxic tau clumps

Brain protein CUL5 protects neurons by clearing toxic tau clumps

New research initiative aims to develop retinal screening tool for Alzheimer's

New research initiative aims to develop retinal screening tool for Alzheimer's

CTE should be recognized as new cause of dementia, study suggests

CTE should be recognized as new cause of dementia, study suggests

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.